These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 17109973
21. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis. Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Ueno H. Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142 [Abstract] [Full Text] [Related]
22. Thymus-derived CD4+ CD25+ T cells suppress the development of murine allergic conjunctivitis. Sumi T, Fukushima A, Fukuda K, Kumagai N, Nishida T, Takeuchi M, Taguchi O, Ueno H. Int Arch Allergy Immunol; 2007; 143(4):276-81. PubMed ID: 17356295 [Abstract] [Full Text] [Related]
25. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice. Fukushima A, Yamaguchi T, Azuma M, Yagita H, Ueno H. Br J Ophthalmol; 2006 Aug; 90(8):1040-5. PubMed ID: 16613922 [Abstract] [Full Text] [Related]
28. Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase. Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Yagita H, Ueno H. Br J Ophthalmol; 2006 Dec; 90(12):1535-41. PubMed ID: 16914468 [Abstract] [Full Text] [Related]
30. Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection to the allogeneic fetus in abortion-prone matings. Jin LP, Zhou YH, Wang MY, Zhu XY, Li DJ. J Reprod Immunol; 2005 Apr; 65(2):133-46. PubMed ID: 15811518 [Abstract] [Full Text] [Related]
31. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma. Sloots A, Mastini C, Rohrbach F, Weth R, Curcio C, Burkhardt U, Jäger E, Forni G, Cavallo F, Wels WS. Clin Cancer Res; 2008 Nov 01; 14(21):6933-43. PubMed ID: 18980988 [Abstract] [Full Text] [Related]
32. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis. Ishida W, Tsuru E, Tominaga A, Miyazaki JI, Higuchi T, Sakamoto S, Fukushima A. Br J Ophthalmol; 2009 Dec 01; 93(12):1680-5. PubMed ID: 19692377 [Abstract] [Full Text] [Related]
35. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines. NAM JH, BANG HS, CHO HW, CHUNG YH. Acta Virol; 2007 Dec 01; 51(2):125-30. PubMed ID: 17900219 [Abstract] [Full Text] [Related]
38. Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response. Giavina-Bianchi P, Kalil J, Rizzo LV. Acta Ophthalmol; 2008 Sep 01; 86(6):670-5. PubMed ID: 18752518 [Abstract] [Full Text] [Related]
39. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis. Fukuda K, Ohbayashi M, Morohoshi K, Zhang L, Liu FT, Ono SJ. J Allergy Clin Immunol; 2009 Oct 01; 124(4):827-33.e2. PubMed ID: 19660804 [Abstract] [Full Text] [Related]
40. Roles of T-cells in the development of allergic conjunctival diseases. Fukushima A. Cornea; 2007 Oct 01; 26(9 Suppl 1):S36-40. PubMed ID: 17881914 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]